FDA Clears Novel Electronic Patch for Premature Ejaculation Treatment
核心洞察
Morari Medical (搜索)'s innovative MOR device, a drug-free patch using electrical stimulation to delay ejaculation, has received FDA clearance for improving sexual performance in adult males.
The device, developed in Minnesota, works by sending mild electrical impulses to confuse ejaculatory nerve signals, offering an alternative to traditional medications and topical treatments.
Clinical testing demonstrated safety and efficacy, with the device set to launch through a phased rollout starting at $299 for a starter kit.
Morari Medical (搜索) has secured FDA clearance for MOR, a groundbreaking electronic patch designed to address premature ejaculation through neural stimulation technology. This milestone marks a significant advancement in men's sexual health treatment options, offering a drug-free alternative to traditional therapies.
Novel Mechanism of Action
The MOR device employs a unique approach by utilizing mild electrical impulses delivered through a patch placed on the perineum. These signals effectively interrupt the communication between ejaculatory nerves and the brain, thereby delaying ejaculation. Jeff Bennett, founder and CEO of Morari Medical (搜索), developed this innovation drawing from his experience with neural stimulation technology at Medtronic.
Clinical Need and Market Impact
According to Dr. Dicken Ko, a collaborating urologist, premature ejaculation affects 20-30% of men during their lifetime. Current treatment options primarily consist of medications and topical anesthetics, which often come with unwanted side effects. The MOR device presents a non-pharmacological alternative that could address this significant unmet medical need.
Safety and Clinical Development
The company conducted comprehensive testing to ensure the device's safety and effectiveness. Initial feasibility studies involved 10 couples, followed by rigorous evaluation of electrical safety, cybersecurity, and biocompatibility parameters. The FDA clearance specifically indicates the device for stimulating healthy perineal muscles and nerves in adult males to improve sexual performance.
Technical Specifications and Customization
The MOR system includes a smartphone app that allows users to adjust stimulation patterns according to their preferences. Bennett notes that stimulation intensity may need adjustment based on individual physical characteristics such as body composition. The device has been designed with user comfort and safety in mind, including careful testing of adhesive materials for skin compatibility.
Commercial Launch Strategy
Morari Medical (搜索) has outlined a strategic launch plan beginning with a 100-customer pilot program in late March, followed by a 400-customer expansion phase. The company plans a limited market launch, potentially targeting Minneapolis initially. The starter kit, priced at $299, includes a reusable generator, six single-use patches, and a charging system. Manufacturing will be handled by Nextern (搜索), based in Maple Grove.
Financial Outlook
The company has successfully raised $3.2 million in funding and is pursuing an additional $5 million through a series-A investment round later this year. This financial backing supports the commercialization efforts and further development of the technology.